aclacinomycin has been researched along with Graft vs Host Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bo, J; Dou, L; Gao, C; Gao, X; Li, H; Liu, D; Lu, N; Wang, L; Wei, Y; Wu, Y; Zhang, R; Zhu, C | 1 |
| Dickneite, G; Kurrle, R; Sedlacek, HH; Seiler, FR | 1 |
1 trial(s) available for aclacinomycin and Graft vs Host Disease
| Article | Year |
|---|---|
A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.
Topics: Aclarubicin; Adult; Cytarabine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Myelodysplastic Syndromes; Recurrence | 2023 |
1 other study(ies) available for aclacinomycin and Graft vs Host Disease
| Article | Year |
|---|---|
Immunosuppression as a desired pharmacological effect.
Topics: Aclarubicin; Anemia, Hemolytic; Animals; Antibiotics, Antineoplastic; Antibody Formation; Encephalomyelitis, Autoimmune, Experimental; Female; Glomerulonephritis; Graft vs Host Disease; Hemolytic Plaque Technique; Immune Complex Diseases; Immunity, Cellular; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Naphthacenes; Rats; Rats, Inbred Lew | 1984 |